Drug Safety

Overview of Seizure-Inducing Potential of Doripenem
pp. 709-716(8)
Authors: Zhanel, George G.; Ketter, Nzeera; Rubinstein, Ethan; Friedland, Ian; Redman, Rebecca

Benefit-Risk Assessment of Sunitinib in Gastrointestinal Stromal Tumours and Renal Cancer
pp. 717-734(18)
Authors: Theou-Anton, Nathalie; Faivre, Sandrine; Dreyer, Chantal; Raymond, Eric

Comparative Tolerability of Newer Agents for Insomnia
pp. 735-748(14)
Author: Zammit, Gary

Drug-Eluting Stents in Percutaneous Coronary Intervention: A Benefit-Risk Assessment
pp. 749-770(22)
Authors: Byrne, Robert A.; Sarafoff, Nikolaus; Kastrati, Adnan; Schömig, Albert

First-Generation Drug-Eluting Stents … and Beyond
pp. 771-773(3)
Author: Wijns, William

Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates: A Case Series from a Swiss University Hospital
pp. 775-785(11)
Authors: Ing-Lorenzini, Kuntheavy; Desmeules, Jules; Plachta, Olivier; Suva, Domizio; Dayer, Pierre; Peter, Robin

Liver Safety in Patients with Type 2 Diabetes Treated with Pioglitazone: Results from a 3-Year, Randomized, Comparator-Controlled Study in the US
pp. 787-800(14)
Authors: Tolman, Keith G.; Freston, James W.; Kupfer, Stuart; Perez, Alfonso